<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font14">for </span>
   <span class="font14">â€‰ </span>
   <span class="font14">knee </span>
   <span class="font13">with </span>
   <span class="font13">was </span>
   <span class="font13">.â€‰Â±â€‰. </span>
   <span class="font13">THF- </span>
   <span class="font13">patients </span>
   <span class="font13">osteoarthritis </span>
   <span class="font13">pain </span>
   <span class="font13">were </span>
   <span class="font12">diclofenac </span>
   <span class="font12">{background </span>
   <span class="font12">analysis </span>
   <span class="font12">margin </span>
   <span class="font11">oral </span>
   <span class="font11">treatment </span>
   <span class="font11">The </span>
   <span class="font11">[]. </span>
   <span class="font11">from </span>
   <span class="font11">trial </span>
   <span class="font11">{border-style </span>
   <span class="font11">efficacy </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">study </span>
   <span class="font11">this </span>
   <span class="font11">(âˆ’. </span>
   <span class="font11">VAS </span>
   <span class="font11">clinical </span>
   <span class="font11">group </span>
   <span class="font11">safety </span>
   <span class="font11">that </span>
   <span class="font11">had </span>
   <span class="font11">are </span>
   <span class="font11">between </span>
   <span class="font11">change </span>
   <span class="font11">herbal </span>
   <span class="font11">not </span>
   <span class="font11">outcome </span>
   <span class="font11">scale </span>
   <span class="font11">used </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">Journal </span>
   <span class="font10">trials </span>
   <span class="font10">two </span>
   <span class="font10">âˆ’.â€‰Â±â€‰. </span>
   <span class="font10">adverse </span>
   <span class="font10">both </span>
   <span class="font10">other </span>
   <span class="font10">symptomatic </span>
   <span class="font10">âˆ’. </span>
   <span class="font10">Research </span>
   <span class="font10">Thai </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">knee. </span>
   <span class="font10">noninferiority </span>
   <span class="font10">Mean </span>
   <span class="font10">This </span>
   <span class="font10">drugs </span>
   <span class="font10">mean </span>
   <span class="font10">Osteoarthritis </span>
   <span class="font10">Week </span>
   <span class="font10">effects </span>
   <span class="font10">groups </span>
   <span class="font10">have </span>
   <span class="font10">life </span>
   <span class="font10">moderate-to-severe </span>
   <span class="font10">one </span>
   <span class="font10">pharmacological </span>
   <span class="font10">px; </span>
   <span class="font10">test </span>
   <span class="font10">{font-family </span>
   <span class="font10">â€ƒMITT </span>
   <span class="font10">â€ƒPP </span>
   <span class="font10">(Figure </span>
   <span class="font10">MITT </span>
   <span class="font10">[], </span>
   <span class="font10">all </span>
   <span class="font10">baseline </span>
   <span class="font10">been </span>
   <span class="font10">comparison </span>
   <span class="font10">data </span>
   <span class="font10">did </span>
   <span class="font10">end </span>
   <span class="font10">font-size </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">its </span>
   <span class="font10">medications </span>
   <span class="font10">outcomes </span>
   <span class="font10">â€‰mm </span>
   <span class="font10">Clinical </span>
   <span class="font10">Figure </span>
   <span class="font10">KOOS </span>
   <span class="font10">Outcome </span>
   <span class="font10">activities </span>
   <span class="font10">also </span>
   <span class="font10">analysis: </span>
   <span class="font10">any </span>
   <span class="font10">assessed </span>
   <span class="font10">assessment </span>
   <span class="font10">available </span>
   <span class="font10">clinically </span>
   <span class="font10">criteria </span>
   <span class="font10">disease </span>
   <span class="font10">double; </span>
   <span class="font10">each </span>
   <span class="font10">events </span>
   <span class="font10">improvement </span>
   <span class="font10">included </span>
   <span class="font10">measures </span>
   <span class="font10">more </span>
   <span class="font10">most </span>
   <span class="font10">observed </span>
   <span class="font10">osteoarthritis: </span>
   <span class="font10">p=.). </span>
   <span class="font10">significant </span>
   <span class="font10">upper </span>
   <span class="font10">visual </span>
   <span class="font10">which </span>
   <span class="font10">(%) </span>
   <span class="font10">Cartilage./j.joca... </span>
   <span class="font10">Chiang </span>
   <span class="font10">Faculty </span>
   <span class="font10">Mai </span>
   <span class="font10">NSAIDs </span>
   <span class="font10">Sciences </span>
   <span class="font10">Table </span>
   <span class="font10">Trial </span>
   <span class="font10">[â€"]. </span>
   <span class="font10">analog </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">climb </span>
   <span class="font10">common </span>
   <span class="font10">controlled </span>
   <span class="font10">does </span>
   <span class="font10">four </span>
   <span class="font10">function </span>
   <span class="font10">hip </span>
   <span class="font10">including </span>
   <span class="font10">indicating </span>
   <span class="font10">less </span>
   <span class="font10">non-steroidal </span>
   <span class="font10">only </span>
   <span class="font10">osteoarthritic </span>
   <span class="font10">patient </span>
   <span class="font10">placebo </span>
   <span class="font10">present </span>
   <span class="font10">reported </span>
   <span class="font10">reporting </span>
   <span class="font10">scores </span>
   <span class="font10">several </span>
   <span class="font10">six </span>
   <span class="font10">solid; </span>
   <span class="font10">stair </span>
   <span class="font10">symptoms </span>
   <span class="font10">tolerability </span>
   <span class="font10">trial. </span>
   <span class="font10">vs. </span>
   <span class="font10">well </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%) </span>
   <span class="font10">(mm) </span>
   <span class="font10">(nâ€‰=â€‰) </span>
   <span class="font10">-step </span>
   <span class="font10">Albizia </span>
   <span class="font10">Alternative </span>
   <span class="font10">Care </span>
   <span class="font10">Cyperus </span>
   <span class="font10">Department </span>
   <span class="font10">Diclofenac </span>
   <span class="font10">Injury </span>
   <span class="font10">Knee </span>
   <span class="font10">Medicine, </span>
   <span class="font10">NSAIDs, </span>
   <span class="font10">Patients </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">With </span>
   <span class="font10">activities, </span>
   <span class="font10">alternative </span>
   <span class="font10">antioxidant </span>
   <span class="font10">arthritis </span>
   <span class="font10">asper </span>
   <span class="font10">authors </span>
   <span class="font10">bias </span>
   <span class="font10">bold </span>
   <span class="font10">burden </span>
   <span class="font10">comparable </span>
   <span class="font10">conducted </span>
   <span class="font10">courier; </span>
   <span class="font10">diclofenac, </span>
   <span class="font10">difference </span>
   <span class="font10">drug </span>
   <span class="font10">due </span>
   <span class="font10">em; </span>
   <span class="font10">enrolled </span>
   <span class="font10">following </span>
   <span class="font10">group, </span>
   <span class="font10">has </span>
   <span class="font10">higher </span>
   <span class="font10">least </span>
   <span class="font10">limit </span>
   <span class="font10">nigrum </span>
   <span class="font10">noninferior </span>
   <span class="font10">number </span>
   <span class="font10">overall </span>
   <span class="font10">pain. </span>
   <span class="font10">phase </span>
   <span class="font10">primary </span>
   <span class="font10">procera </span>
   <span class="font10">pt;} </span>
   <span class="font10">quality </span>
   <span class="font10">randomised </span>
   <span class="font10">randomized, </span>
   <span class="font10">reasonable </span>
   <span class="font10">relief </span>
   <span class="font10">risk </span>
   <span class="font10">rotundus </span>
   <span class="font10">run-in </span>
   <span class="font10">score </span>
   <span class="font10">support </span>
   <span class="font10">test, </span>
   <span class="font10">their </span>
   <span class="font10">therapeutic </span>
   <span class="font10">they </span>
   <span class="font10">three </span>
   <span class="font10">times </span>
   <span class="font10">trial, </span>
   <span class="font10">two-sided </span>
   <span class="font10">use </span>
   <span class="font10">using </span>
   <span class="font10">within </span>
  </p>
 </body>
</html>
